These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7035579)
21. Cellular elements in the resistance to candida infection in mice. I. Contribution of T lymphocytes and phagocytes at various stages of infection. Miyake T; Takeya K; Nomoto K; Muraoka S Microbiol Immunol; 1977; 21(12):703-25. PubMed ID: 347226 [TBL] [Abstract][Full Text] [Related]
22. Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis. Borg M; RĂ¼chel R J Med Vet Mycol; 1990; 28(1):3-14. PubMed ID: 2194017 [TBL] [Abstract][Full Text] [Related]
23. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052 [TBL] [Abstract][Full Text] [Related]
24. Examination of the pathogenic potential of Candida albicans filamentous cells in an animal model of haematogenously disseminated candidiasis. Cleary IA; Reinhard SM; Lazzell AL; Monteagudo C; Thomas DP; Lopez-Ribot JL; Saville SP FEMS Yeast Res; 2016 Mar; 16(2):fow011. PubMed ID: 26851404 [TBL] [Abstract][Full Text] [Related]
25. Activation of murine invariant NKT cells promotes susceptibility to candidiasis by IL-10 induced modulation of phagocyte antifungal activity. Haraguchi N; Kikuchi N; Morishima Y; Matsuyama M; Sakurai H; Shibuya A; Shibuya K; Taniguchi M; Ishii Y Eur J Immunol; 2016 Jul; 46(7):1691-703. PubMed ID: 27151377 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of immunotherapy in invasive candidiasis: antifungal activity and cytokine expression assays. Simitsopoulou M; Roilides E Methods Mol Med; 2005; 118():161-79. PubMed ID: 15888942 [TBL] [Abstract][Full Text] [Related]
27. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis. Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477 [TBL] [Abstract][Full Text] [Related]
29. Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Schuit KE Infect Immun; 1979 Jun; 24(3):932-8. PubMed ID: 381207 [TBL] [Abstract][Full Text] [Related]
30. Role of yeast cell growth temperature on Candida albicans virulence in mice. Antley PP; Hazen KC Infect Immun; 1988 Nov; 56(11):2884-90. PubMed ID: 3049375 [TBL] [Abstract][Full Text] [Related]
31. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection. Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189 [TBL] [Abstract][Full Text] [Related]
32. [Inflammation and resistance of mice infected by "Candida albicans" (author's transl)]. Hurtrel B; Lagrange PH; Michel JC Ann Immunol (Paris); 1978; 129 C(6):843-6. PubMed ID: 371518 [TBL] [Abstract][Full Text] [Related]
33. Pulmonary defence mechanism in mice. A comparative role of alveolar macrophages and polymorphonuclear cells against infection with Candida albicans. Lal S; Mitsuyama M; Miyata M; Ogata N; Amako K; Nomoto K J Clin Lab Immunol; 1986 Mar; 19(3):127-33. PubMed ID: 3519975 [TBL] [Abstract][Full Text] [Related]
34. Influence of fluconazole on phagocytosis, oxidative burst and killing activity of human phagocytes. Using a flow cytometric method with whole blood. Baldauf C; Adam D Eur J Med Res; 2000 Oct; 5(10):455-9. PubMed ID: 11076789 [TBL] [Abstract][Full Text] [Related]
35. Enumeration of viable Candida albicans blastospores using tetrabromofluorescein (eosin Y) and flow cytometry. Costantino PJ; Budd DE; Gare NF Cytometry; 1995 Apr; 19(4):370-5. PubMed ID: 7540973 [TBL] [Abstract][Full Text] [Related]
36. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms. Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303 [TBL] [Abstract][Full Text] [Related]
37. Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis. Rane HS; Hardison S; Botelho C; Bernardo SM; Wormley F; Lee SA Virulence; 2014; 5(8):810-8. PubMed ID: 25483774 [TBL] [Abstract][Full Text] [Related]
38. Differential phagocytosis of white versus opaque Candida albicans by Drosophila and mouse phagocytes. Lohse MB; Johnson AD PLoS One; 2008 Jan; 3(1):e1473. PubMed ID: 18213381 [TBL] [Abstract][Full Text] [Related]
39. Effect of phenotypic switching on expression of virulence factors by Candida albicans causing candidiasis in diabetic patients. Antony G; Saralaya V; Gopalkrishna Bhat K; Shalini Shenoy M; Shivananda PG Rev Iberoam Micol; 2009 Sep; 26(3):202-5. PubMed ID: 19635443 [TBL] [Abstract][Full Text] [Related]
40. Rapid differentiation of Candida albicans from other Candida species using its unique germ tube formation at 39 degrees C. Kim D; Shin WS; Lee KH; Kim K; Young Park J; Koh CM Yeast; 2002 Aug; 19(11):957-62. PubMed ID: 12125052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]